Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.15
-0.0250-0.79%
Volume:6.95M
Turnover:22.13M
Market Cap:1.66B
PE:-2.18
High:3.26
Open:3.10
Low:3.10
Close:3.17
52wk High:7.18
52wk Low:2.98
Shares:527.40M
Float Shares:415.00M
Volume Ratio:0.57
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4410
EPS(LYR):-1.4410
ROE:-59.54%
ROA:-27.72%
PB:1.47
PE(LYR):-2.18

Loading ...

Jul 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jun 27, 2024

Proposed Sale Of Securities

Form144 | Recursion Pharmaceuticals' Officer Tina Marriott proposes to sell 6000 Shares, with a total value of approximately $43290.
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Proposed Sale Of Securities

Form144|Recursion Pharmaceuticals' Director Blake Borgeson proposes to sell 11447 Shares, with a total value of approximately $1.09 Million.
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2024

Correspondence

Form CORRESP - Correspondence
Jun 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 07, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 31, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2024

Major Issues Report

Form 8-K - Current report
May 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 10, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 09, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities